Descriptor English: | Doxepin | ||||
Descriptor Spanish: |
Doxepina
| ||||
Descriptor Portuguese: | Doxepina | ||||
Descriptor French: | Doxépine | ||||
Entry term(s): |
Apo Doxepin Apo-Doxepin ApoDoxepin Aponal Deptran Desidox Doneurin Doxepia Doxepin Hydrochloride Doxepin Hydrochloride, Cis-Trans Isomer Mixture (approximately 1:5) Doxepin RPh Doxepin beta Doxepin-RPh Espadox Hydrochloride, Doxepin Mareen Novo Doxepin Novo-Doxepin Prudoxin Quitaxon Sinequan Sinquan Xepin Zonalon |
||||
Tree number(s): |
D02.355.291.852.500 D03.633.300.382.393 |
||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D004316 | ||||
Scope note: | A dibenzoxepin tricyclic compound. It displays a range of pharmacological actions including maintaining adrenergic innervation. Its mechanism of action is not fully understood, but it appears to block reuptake of monoaminergic neurotransmitters into presynaptic terminals. It also possesses anticholinergic activity and modulates antagonism of histamine H(1)- and H(2)-receptors. |
||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||
Pharm Action: |
Sleep Aids, Pharmaceutical Antidepressive Agents, Tricyclic Histamine Antagonists |
||||
Registry Number: | 1668-19-5 | ||||
CAS Type 1 Name: | 1-Propanamine, 3-dibenz(b,e)oxepin-11(6H)-ylidene-N,N-dimethyl- | ||||
Public MeSH Note: | 74 |
||||
History Note: | 74 |
||||
DeCS ID: | 4375 | ||||
Unique ID: | D004316 | ||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||
Date Established: | 1974/01/01 | ||||
Date of Entry: | 1999/01/01 | ||||
Revision Date: | 2016/05/31 |
-
-
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals -
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds
|
Doxepin
- Preferred
Deptran
- Narrower
Desidox
- Narrower
Doneurin
- Narrower
Doxepia
- Narrower
Doxepin beta
- Narrower
Doxepin Hydrochloride
- Narrower
Doxepin-RPh
- Narrower
Espadox
- Narrower
Mareen
- Narrower
Novo-Doxepin
- Narrower
Prudoxin
- Narrower
Quitaxon
- Narrower
Sinequan
- Narrower
Zonalon
- Narrower
Aponal
- Narrower
Apo-Doxepin
- Narrower
Concept UI |
M0006782 |
Scope note | A dibenzoxepin tricyclic compound. It displays a range of pharmacological actions including maintaining adrenergic innervation. Its mechanism of action is not fully understood, but it appears to block reuptake of monoaminergic neurotransmitters into presynaptic terminals. It also possesses anticholinergic activity and modulates antagonism of histamine H(1)- and H(2)-receptors. |
Preferred term | Doxepin |
Concept UI |
M0485388 |
Preferred term | Deptran |
Concept UI |
M0485387 |
Preferred term | Desidox |
Concept UI |
M0492464 |
Preferred term | Doneurin |
Concept UI |
M0492463 |
Preferred term | Doxepia |
Concept UI |
M0492460 |
Preferred term | Doxepin beta |
Concept UI |
M0330406 |
Preferred term | Doxepin Hydrochloride |
Entry term(s) |
Doxepin Hydrochloride, Cis-Trans Isomer Mixture (approximately 1:5) Hydrochloride, Doxepin |
Concept UI |
M0492471 |
Preferred term | Doxepin-RPh |
Entry term(s) |
Doxepin RPh |
Concept UI |
M0492469 |
Preferred term | Espadox |
Concept UI |
M0492468 |
Preferred term | Mareen |
Concept UI |
M0492467 |
Preferred term | Novo-Doxepin |
Entry term(s) |
Novo Doxepin |
Concept UI |
M0492466 |
Preferred term | Prudoxin |
Concept UI |
M0492465 |
Preferred term | Quitaxon |
Concept UI |
M0006783 |
Preferred term | Sinequan |
Entry term(s) |
Sinquan |
Concept UI |
M0354084 |
Preferred term | Zonalon |
Entry term(s) |
Xepin |
Concept UI |
M0485389 |
Preferred term | Aponal |
Concept UI |
M0485390 |
Preferred term | Apo-Doxepin |
Entry term(s) |
Apo Doxepin ApoDoxepin |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey